Theresa Jaso

Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection

Katherine M. Shea, Athena L V Hobbs, Theresa Jaso et al. · Antimicrobial Agents and Chemotherapy · 2017 · 45 citations · Full text

Are first-generation cephalosporins obsolete? A retrospective, non-inferiority, cohort study comparing empirical therapy with cefazolin versus ceftriaxone for acute pyelonephritis in hospitalized patients

Athena L V Hobbs, Katherine M. Shea, Mitchell J. Daley et al. · Journal of Antimicrobial Chemotherapy · 2016 · 16 citations · Full text

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study

Christopher R. Frei, Theresa Jaso, Eric M. Mortensen et al. · Current Medical Research and Opinion · 2009 · 13 citations

Oral β-lactams vs fluoroquinolones and trimethoprim/sulfamethoxazole for step-down therapy for<i>Escherichia coli</i>,<i>Proteus mirabilis</i>, and<i>Klebsiella pneumoniae</i>bacteremia

Michael J McAlister, Dusten T. Rose, F. Parker Hudson et al. · American Journal of Health-System Pharmacy · 2022 · 11 citations